登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Science，2月26日，Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2021-03-03

  • Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
    Mads Delbo Larsen1,2,*, View ORCID ProfileErik L. de Graaf1,2,*, Myrthe E. Sonneveld1,2,*, View ORCID ProfileH. Rosina Plomp3, Jan Nouta3, View ORCID ProfileWilliann...

    Science  26 Feb 2021:
    Vol. 371, Issue 6532, eabc8378
    DOI: 10.1126/science.abc8378

    Structured Abstract
    INTRODUCTION
    Antibody function is often considered static and mostly determined by isotype and subclass. The conserved N-linked glycan at position 297 in the Fc domain of immunoglobulin G (IgG) is essential for an antibody’s effector functions. Moreover, this glycan is highly variable and functionally relevant, especially for the core fucose moiety. IgG lacking core fucosylation (afucosylated IgG) causes increased antibody-dependent cellular cytotoxicity (ADCC) through highly increased IgG-Fc receptor IIIa (FcγRIIIa) affinity. Despite constant levels of total plasma IgG-Fc fucosylation above 90%, specific IgG responses with low core fucosylation have been sporadically reported. These are directed against alloantigens on blood cells and glycoproteins of HIV and dengue virus. In this study, we investigated the induction of afucosylated IgG to various antigens and delineated its dynamics and proinflammatory potential in COVID-19.

    RATIONALE
    Afucosylated IgG responses have only been found in various alloimmune responses against cellular blood groups and two enveloped viruses. Therefore, we tested the hypothesis that foreign surface–exposed, membrane-embedded proteins induce a specific B cell response that results in afucosylated IgG. We compared immune responses to natural infections by enveloped viruses and nonenveloped viruses, protein subunit vaccination, and live attenuated virus vaccinations. We also assessed the relation to the clinical outcome of such a response in COVID-19.

  • 原文来源：https://science.sciencemag.org/content/371/6532/eabc8378
105浏览量
原文链接
相关报告

  • 《Science，11月27日，Viral epitope profiling of COVID-19 patients》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-12-22
    • Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity View ORCID ProfileEllen Shrock1,2,*, View ORCID ProfileEric Fujimura1,2,3,*, View ORCID ProfileTomasz Kula1,2,†, View ORCID ProfileRichard T. Timms1,2,†, View ORCID ProfileI-Hsiu Lee4, View ORCID ProfileYumei Leng1,2,... Science  27 Nov 2020: Vol. 370, Issue 6520, eabd4250 DOI: 10.1126/science.abd4250 Structured Abstract INTRODUCTION A systematic characterization of the humoral response to severe acute respiratory system coronavirus 2 (SARS-CoV-2) epitopes has yet to be performed. This analysis is important for understanding the immunogenicity of the viral proteome and the basis for cross-reactivity with the common-cold coronaviruses. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is notable for its variable course, with some individuals remaining asymptomatic whereas others experience fever, respiratory distress, or even death. A comprehensive investigation of the antibody response in individuals with severe versus mild COVID-19—as well as an examination of past viral exposure history—is needed. RATIONALE An understanding of humoral responses to SARS-CoV-2 is critical for improving diagnostics and vaccines and gaining insight into variable clinical outcomes. To this end, we used VirScan, a high-throughput method to analyze epitopes of antiviral antibodies in human sera. We supplemented the original VirScan library with additional libraries of peptides spanning the proteomes of SARS-CoV-2 and all other human coronaviruses. These libraries enabled us to precisely map epitope locations and investigate cross-reactivity between SARS-CoV-2 and other coronavirus strains. The original VirScan library allowed us to simultaneously investigate antibody responses to prior infections and viral exposure history.
    119浏览量
    原文链接

  • 《MedRixv，2月23日，Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-24
    • Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19 Irani Thevarajan, Thi HO Nguyen, Marios Koutsakos, Julian Druce, Leon Caly, Carolien E van de Sandt, Xiaoxiao Jia, Suellen Nicholson, Mike Catton, Benjamin Cowie, Steven Tong, Sharon Lewin, Katherine Kedzierska doi: https://doi.org/10.1101/2020.02.20.20025841 Abstract We report the kinetics of the immune response in relation to clinical and virological features of a patient with mild-to-moderate coronavirus disease-19 (COVID-19) requiring hospitalisation. Increased antibody-secreting cells, follicular T-helper cells, activated CD4+ and CD8+ T-cells and IgM/IgG SARS-CoV-2-binding antibodies were detected in blood, prior to symptomatic recovery. These immunological changes persisted for at least 7 days following full resolution of symptoms, indicating substantial anti-viral immunity in this non-severe COVID-19. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    44浏览量
    原文链接